Prepositioning antibiotics for anthrax:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
2012
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | "If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a large number of people following an anthrax attack have been greatly enhanced during the last decade, many public health authorities and policy experts fear that the nation's current systems and plans are insufficient to respond to the most challenging scenarios, such as a very large-scale anthrax attack. The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response commissioned the Institute of Medicine to examine the potential uses, benefits, and disadvantages of strategies for repositioning antibiotics. This involves storing antibiotics close to or in the possession of the people who would need rapid access to them should an attack occur. Prepositioning Antibiotics for Anthrax reviews the scientific evidence on the time window in which antibiotics successfully prevent anthrax and the implications for decision making about prepositioning, describes potential prepositioning strategies, and develops a framework to assist state, local, and tribal public health authorities in determining whether prepositioning strategies would be beneficial for their communities. However, based on an analysis of the likely health benefits, health risks, and relative costs of the different prepositioning strategies, the book also develops findings and recommendations to provide jurisdictions with some practical insights as to the circumstances in which different prepositioning strategies may be beneficial. Finally, the book identifies federal- and national-level actions that would facilitate the evaluation and development of prepositioning strategies. Recognizing that communities across the nation have differing needs and capabilities, the findings presented in this report are intended to assist public health officials in considering the benefits, costs, and trade-offs involved in developing alternative prepositioning strategies appropriate to their particular communities"--Publisher's description Includes bibliographical references and index Introduction -- Antibiotics for anthrax postexposure prophylaxis -- Current dispensing strategies for medical countermasures for anthrax -- Prepositioning strategies -- A decision-aiding framework -- Recommended actions for moving forward |
| Beschreibung: | 1 Online-Ressource (xiv, 343 p.) |
| ISBN: | 9780309218085 030921808X 9780309218092 0309218098 1280123206 9781280123207 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042795618 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150902s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 9780309218085 |9 978-0-309-21808-5 | ||
| 020 | |a 030921808X |9 0-309-21808-X | ||
| 020 | |a 9780309218092 |c electronic bk. |9 978-0-309-21809-2 | ||
| 020 | |a 0309218098 |c electronic bk. |9 0-309-21809-8 | ||
| 020 | |a 1280123206 |9 1-280-12320-6 | ||
| 020 | |a 9781280123207 |9 978-1-280-12320-7 | ||
| 035 | |a (OCoLC)775688619 | ||
| 035 | |a (DE-599)BVBBV042795618 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.95/6 |2 23 | |
| 245 | 1 | 0 | |a Prepositioning antibiotics for anthrax |c Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c 2012 | |
| 300 | |a 1 Online-Ressource (xiv, 343 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a "If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a large number of people following an anthrax attack have been greatly enhanced during the last decade, many public health authorities and policy experts fear that the nation's current systems and plans are insufficient to respond to the most challenging scenarios, such as a very large-scale anthrax attack. The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response commissioned the Institute of Medicine to examine the potential uses, benefits, and disadvantages of strategies for repositioning antibiotics. | ||
| 500 | |a This involves storing antibiotics close to or in the possession of the people who would need rapid access to them should an attack occur. Prepositioning Antibiotics for Anthrax reviews the scientific evidence on the time window in which antibiotics successfully prevent anthrax and the implications for decision making about prepositioning, describes potential prepositioning strategies, and develops a framework to assist state, local, and tribal public health authorities in determining whether prepositioning strategies would be beneficial for their communities. However, based on an analysis of the likely health benefits, health risks, and relative costs of the different prepositioning strategies, the book also develops findings and recommendations to provide jurisdictions with some practical insights as to the circumstances in which different prepositioning strategies may be beneficial. | ||
| 500 | |a Finally, the book identifies federal- and national-level actions that would facilitate the evaluation and development of prepositioning strategies. Recognizing that communities across the nation have differing needs and capabilities, the findings presented in this report are intended to assist public health officials in considering the benefits, costs, and trade-offs involved in developing alternative prepositioning strategies appropriate to their particular communities"--Publisher's description | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Introduction -- Antibiotics for anthrax postexposure prophylaxis -- Current dispensing strategies for medical countermasures for anthrax -- Prepositioning strategies -- A decision-aiding framework -- Recommended actions for moving forward | ||
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Contagious |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Infectious Diseases |2 bisacsh | |
| 650 | 4 | |a Anthrax / prevention & control / United States | |
| 650 | 4 | |a Anthrax / drug therapy / United States | |
| 650 | 4 | |a Anti-Bacterial Agents / supply & distribution / United States | |
| 650 | 4 | |a Bioterrorism / prevention & control / United States | |
| 650 | 4 | |a Disaster Planning / United States | |
| 650 | 4 | |a Post-Exposure Prophylaxis / organization & administration / United States | |
| 650 | 4 | |a Time Factors / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Anthrax |z United States |x Prevention | |
| 650 | 4 | |a Biological warfare |z United States |x Safety measures |x Evaluation | |
| 650 | 4 | |a Bioterrorism |z United States |x Prevention |x Evaluation | |
| 650 | 4 | |a Bioterrorism |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Stroud, Clare |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Committee on Prepositioned Medical Countermeasures for the Public |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444947 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA |a ZDB-4-NLEBK | ||
| 940 | 1 | |q FAW_PDA_EBA | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028225391 | ||
Datensatz im Suchindex
| _version_ | 1804175028912128000 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042795618 |
| collection | ZDB-4-EBA ZDB-4-NLEBK |
| ctrlnum | (OCoLC)775688619 (DE-599)BVBBV042795618 |
| dewey-full | 616.95/6 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.95/6 |
| dewey-search | 616.95/6 |
| dewey-sort | 3616.95 16 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05011nmm a2200613zc 4500</leader><controlfield tag="001">BV042795618</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150902s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309218085</subfield><subfield code="9">978-0-309-21808-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030921808X</subfield><subfield code="9">0-309-21808-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309218092</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-21809-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309218098</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-21809-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280123206</subfield><subfield code="9">1-280-12320-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280123207</subfield><subfield code="9">978-1-280-12320-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)775688619</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042795618</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.95/6</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prepositioning antibiotics for anthrax</subfield><subfield code="c">Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiv, 343 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a large number of people following an anthrax attack have been greatly enhanced during the last decade, many public health authorities and policy experts fear that the nation's current systems and plans are insufficient to respond to the most challenging scenarios, such as a very large-scale anthrax attack. The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response commissioned the Institute of Medicine to examine the potential uses, benefits, and disadvantages of strategies for repositioning antibiotics. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This involves storing antibiotics close to or in the possession of the people who would need rapid access to them should an attack occur. Prepositioning Antibiotics for Anthrax reviews the scientific evidence on the time window in which antibiotics successfully prevent anthrax and the implications for decision making about prepositioning, describes potential prepositioning strategies, and develops a framework to assist state, local, and tribal public health authorities in determining whether prepositioning strategies would be beneficial for their communities. However, based on an analysis of the likely health benefits, health risks, and relative costs of the different prepositioning strategies, the book also develops findings and recommendations to provide jurisdictions with some practical insights as to the circumstances in which different prepositioning strategies may be beneficial. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Finally, the book identifies federal- and national-level actions that would facilitate the evaluation and development of prepositioning strategies. Recognizing that communities across the nation have differing needs and capabilities, the findings presented in this report are intended to assist public health officials in considering the benefits, costs, and trade-offs involved in developing alternative prepositioning strategies appropriate to their particular communities"--Publisher's description</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- Antibiotics for anthrax postexposure prophylaxis -- Current dispensing strategies for medical countermasures for anthrax -- Prepositioning strategies -- A decision-aiding framework -- Recommended actions for moving forward</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Contagious</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Infectious Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anthrax / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anthrax / drug therapy / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Bacterial Agents / supply & distribution / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disaster Planning / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Post-Exposure Prophylaxis / organization & administration / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Time Factors / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anthrax</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological warfare</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroud, Clare</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on Prepositioned Medical Countermeasures for the Public</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444947</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028225391</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV042795618 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:09:47Z |
| institution | BVB |
| isbn | 9780309218085 030921808X 9780309218092 0309218098 1280123206 9781280123207 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028225391 |
| oclc_num | 775688619 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiv, 343 p.) |
| psigel | ZDB-4-EBA ZDB-4-NLEBK FAW_PDA_EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Prepositioning antibiotics for anthrax Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies Washington, D.C. National Academies Press 2012 1 Online-Ressource (xiv, 343 p.) txt rdacontent c rdamedia cr rdacarrier "If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a large number of people following an anthrax attack have been greatly enhanced during the last decade, many public health authorities and policy experts fear that the nation's current systems and plans are insufficient to respond to the most challenging scenarios, such as a very large-scale anthrax attack. The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response commissioned the Institute of Medicine to examine the potential uses, benefits, and disadvantages of strategies for repositioning antibiotics. This involves storing antibiotics close to or in the possession of the people who would need rapid access to them should an attack occur. Prepositioning Antibiotics for Anthrax reviews the scientific evidence on the time window in which antibiotics successfully prevent anthrax and the implications for decision making about prepositioning, describes potential prepositioning strategies, and develops a framework to assist state, local, and tribal public health authorities in determining whether prepositioning strategies would be beneficial for their communities. However, based on an analysis of the likely health benefits, health risks, and relative costs of the different prepositioning strategies, the book also develops findings and recommendations to provide jurisdictions with some practical insights as to the circumstances in which different prepositioning strategies may be beneficial. Finally, the book identifies federal- and national-level actions that would facilitate the evaluation and development of prepositioning strategies. Recognizing that communities across the nation have differing needs and capabilities, the findings presented in this report are intended to assist public health officials in considering the benefits, costs, and trade-offs involved in developing alternative prepositioning strategies appropriate to their particular communities"--Publisher's description Includes bibliographical references and index Introduction -- Antibiotics for anthrax postexposure prophylaxis -- Current dispensing strategies for medical countermasures for anthrax -- Prepositioning strategies -- A decision-aiding framework -- Recommended actions for moving forward HEALTH & FITNESS / Diseases / Contagious bisacsh MEDICAL / Infectious Diseases bisacsh Anthrax / prevention & control / United States Anthrax / drug therapy / United States Anti-Bacterial Agents / supply & distribution / United States Bioterrorism / prevention & control / United States Disaster Planning / United States Post-Exposure Prophylaxis / organization & administration / United States Time Factors / United States Medizin Anthrax United States Prevention Biological warfare United States Safety measures Evaluation Bioterrorism United States Prevention Evaluation Bioterrorism United States USA Stroud, Clare Sonstige oth Institute of Medicine (U.S.) Committee on Prepositioned Medical Countermeasures for the Public Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444947 Aggregator Volltext |
| spellingShingle | Prepositioning antibiotics for anthrax HEALTH & FITNESS / Diseases / Contagious bisacsh MEDICAL / Infectious Diseases bisacsh Anthrax / prevention & control / United States Anthrax / drug therapy / United States Anti-Bacterial Agents / supply & distribution / United States Bioterrorism / prevention & control / United States Disaster Planning / United States Post-Exposure Prophylaxis / organization & administration / United States Time Factors / United States Medizin Anthrax United States Prevention Biological warfare United States Safety measures Evaluation Bioterrorism United States Prevention Evaluation Bioterrorism United States |
| title | Prepositioning antibiotics for anthrax |
| title_auth | Prepositioning antibiotics for anthrax |
| title_exact_search | Prepositioning antibiotics for anthrax |
| title_full | Prepositioning antibiotics for anthrax Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies |
| title_fullStr | Prepositioning antibiotics for anthrax Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies |
| title_full_unstemmed | Prepositioning antibiotics for anthrax Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud ... [et al.] ; Institute of Medicine of the National Academies |
| title_short | Prepositioning antibiotics for anthrax |
| title_sort | prepositioning antibiotics for anthrax |
| topic | HEALTH & FITNESS / Diseases / Contagious bisacsh MEDICAL / Infectious Diseases bisacsh Anthrax / prevention & control / United States Anthrax / drug therapy / United States Anti-Bacterial Agents / supply & distribution / United States Bioterrorism / prevention & control / United States Disaster Planning / United States Post-Exposure Prophylaxis / organization & administration / United States Time Factors / United States Medizin Anthrax United States Prevention Biological warfare United States Safety measures Evaluation Bioterrorism United States Prevention Evaluation Bioterrorism United States |
| topic_facet | HEALTH & FITNESS / Diseases / Contagious MEDICAL / Infectious Diseases Anthrax / prevention & control / United States Anthrax / drug therapy / United States Anti-Bacterial Agents / supply & distribution / United States Bioterrorism / prevention & control / United States Disaster Planning / United States Post-Exposure Prophylaxis / organization & administration / United States Time Factors / United States Medizin Anthrax United States Prevention Biological warfare United States Safety measures Evaluation Bioterrorism United States Prevention Evaluation Bioterrorism United States USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444947 |
| work_keys_str_mv | AT stroudclare prepositioningantibioticsforanthrax AT instituteofmedicineuscommitteeonprepositionedmedicalcountermeasuresforthepublic prepositioningantibioticsforanthrax |